Clinical Trial Update: Toripalimab for High-risk Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating toripalimab for high-risk locally advanced cervical cancer is active but not recruiting, sponsored by the Cancer Institute and Hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Cervical Cancers | Phase 2 | Status: ACTIVE_NOT_RECRUITING